Public Release: 

Past and present of imaging modalities used for prostate cancer diagnosis

This article by Dr. Ghulam Murtaza et al. is published in Current Medical Imaging Reviews, Volume 14, Issue 6, 2018

Bentham Science Publishers


IMAGE: This review illustrates a perspective on prostate cancer imaging summarizing current imaging approaches with a special focus on Prostate Specific Membrane Antigen (PSMA), Bombesin (BN) and Androgen Receptor (AR) targeted... view more 

Credit: Dr. Ghulam Murtaza, Bentham Science Publishers

Prostate cancer is the second prevent type of cancer that exists. Prostate cancer is usually a slowly progressing disease but it can sometimes manifest as an aggressive cancer. Prostate imaging is the primary way to diagnose the disease and this necessity drives its demand in the clinic.

This review covers traditional and new imaging methods for screening the prostate gland for the occurrence of neoplasms. A special focus is given to Prostate Specific Membrane Antigen (PSMA), Bombesin (BN) and Androgen Receptor (AR) targeted imaging using Positron Emission Tomography (PET) and Single Positron Emission Computed Tomography (SPECT) based on 99mTc and other radiotracers.

The reviewers conclude that androgen receptor based imaging is the future direction for prostate specific imaging and can be a better way to diagnose prostate cancer using non-steroidal antiandrogen agents.


The article is Open Access till 31st January, 2019. To obtain the article, please visit:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.